Search Within

Vanessa A Fabrizio

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
Groups
  1. Biostatistics Service (7)
  2. Epidemiology and Biostatistics (7)
  3. Pediatrics, Department of (7)
  4. Sloan Kettering Institute Postdocs (7)
  5. Stem Cell Transplantation and Cellular Therapy Service (7)
  6. Tow Center for Developmental Oncology (TCDO) (7)

More Groups

People
  1. Audrey Mauguen (7)
  2. Richard O'Reilly (6)
  3. Susan Prockop (6)
  4. Jaap Jan Boelens (4)
  5. Kevin Curran (4)
  6. Andromachi Scaradavou (3)

More People

Years
  1. 2021 (2)
  2. 2020 (3)
  3. 2019 (2)
Publications
  1. Bone Marrow Transplantation (2)
  2. Biology of Blood and Marrow Transplantation (1)
  3. Blood (1)
  4. Blood Advances (1)
  5. Cytotherapy (1)
  6. Pediatric Blood and Cancer (1)
Publishers
  1. American Society of Hematology (2)
  2. Nature Publishing Group (2)
  3. Elsevier Inc. (1)
  4. Elsevier Science Ltd. (1)
  5. Wiley Periodicals, Inc (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fludarabine-exposure predicts disease control following CD19-specific CAR T cell (tisagenlecleucel); A report from pediatric real-world CAR Consortium
    Meeting Abstract

    Curran, K. J.; Fabrizio, V. A.; Mauguen, A.; Boelens, J. J.; Baggott, C.; Prabhu, S.; Placenta, H.; Phillips, C. L.; Rossoff, J.; Stefanski, H.; more...
    Cytotherapy (2021)

    Fulltext@MSK | Save
  • Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4(+) immunity to mediate durable responses
    Journal Article

    Fabrizio, V. A.; Rodriguez-Sanchez, M. I.; Mauguen, A.; Dahi, P. B.; Doubrovina, E.; O'Reilly, R. J.; Prockop, S. E.
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV CTLS for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P.; Doubrovina, E.; O'Reilly, R. J.; Prockop, S.
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant
    Journal Article

    Fabrizio, V. A.; Kernan, N. A.; Boulad, F.; Cancio, M.; Allen, J.; Higman, M.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV cytotoxic T-Cells for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P. B.; O'Reilly, R. J.; Prockop, S. E.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Allogeneic CD34-selected HSCT following CAR T-cells is associated with low TRM and favorable OS in pediatric/young adult patients with relapsed/refractory B-ALL
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M. I.; Higman, M. A.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; Shah, N. C.; Spitzer, B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save